Insider Stock Trading History of Klingenstein Paul H

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Klingenstein Paul H since year 2005. The trader's CIK number is 935463. At the time of this reporting, Klingenstein Paul H is the Director of Conatus Pharmaceuticals Inc . (stock ticker symbol CNAT). See this page for all insider trading activities at Conatus Pharmaceuticals Inc .

Note that in the past KLINGENSTEIN PAUL H also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Klingenstein Paul H since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2013-07-30 CNAT Conatus Pharmaceuticals Inc Buy 107,422 11.00 1,181,642
2013-07-30 CNAT Conatus Pharmaceuticals Inc Sale 566 11.00 6,226
2011-11-21 CLVS Clovis Oncology, Inc. Buy 399,291 13.00 5,190,783
2010-11-30 ANAC Anacor Pharmaceuticals Inc Buy 300,000 5.00 1,500,000
2009-02-24 ETRM Enteromedics Inc Buy 1,237,113 1.15 1,422,679
2008-05-29 ETRM Enteromedics Inc Buy 12,200 4.50 54,900
2008-06-02 ETRM Enteromedics Inc Buy 80,000 4.50 360,000
2008-05-23 ETRM Enteromedics Inc Buy 50,000 4.50 225,000
2008-05-19 ETRM Enteromedics Inc Buy 70,000 4.78 334,600
2008-05-20 ETRM Enteromedics Inc Buy 30,000 4.75 142,500
2007-11-15 ETRM Enteromedics Inc Buy 250,000 8.00 2,000,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Klingenstein Paul H (Director of Conatus Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.